Get App Open
In App
Lending
Lending
Open App

SBI Healthcare Opportunities Fund - Regular Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
Fund House : SBI Mutual Fund
  • NAV
    : ₹ 433.6366 -0.01%
    (as on 13th November, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 92% investment in domestic equities of which 28.84% is in Large Cap stocks, 13.23% is in Mid Cap stocks, 7.09% in Small Cap stocks.The fund has 0.07% investment in Debt, of which 0.07% in Government securities.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 12th November, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 06-Nov-25 10017.10 0.17% - 1.08% 202/242
1 Month 13-Oct-25 9992.50 -0.07% - 1.56% 204/239
3 Month 13-Aug-25 10017.50 0.18% - 4.31% 219/236
6 Month 13-May-25 10448.40 4.48% - 8.08% 191/226
YTD 01-Jan-25 9900.80 -0.99% - 4.39% 151/213
1 Year 13-Nov-24 10526.50 5.26% 5.28% 7.43% 121/199
2 Year 13-Nov-23 15327.00 53.27% 23.80% 18.97% 26/153
3 Year 11-Nov-22 19462.30 94.62% 24.80% 18.78% 21/129
5 Year 13-Nov-20 24198.00 141.98% 19.33% 20.92% 55/105
10 Year 13-Nov-15 30194.30 201.94% 11.68% 14.64% 69/76
Since Inception 31-Dec-04 196315.80 1863.16% 15.33% 12.58% 101/240

SIP Returns (NAV as on 12th November, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 13-Nov-24 12000 12388.67 3.24 % 6.06 %
2 Year 13-Nov-23 24000 27421.12 14.25 % 13.39 %
3 Year 11-Nov-22 36000 49180.92 36.61 % 21.33 %
5 Year 13-Nov-20 60000 97917.73 63.2 % 19.67 %
10 Year 13-Nov-15 120000 300667.2 150.56 % 17.48 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Oct,2025)

Portfolio Turnover Ratio : 14.00%  |   Category average turnover ratio is 96.83%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 92.00% | F&O Holdings : 0.00%| Foreign Equity Holdings : 4.05%| Total : 96.05%
No of Stocks : 30 (Category Avg - 44.17) | Large Cap Investments : 28.84%| Mid Cap Investments : 13.23% | Small Cap Investments : 7.09% | Other : 46.89%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 4564.9 11.18% 0.24% 13.98% (Apr 2025) 10.86% (Aug 2025) 27.00 L 0.00
Divis Laboratories Ltd. Pharmaceuticals 2964.7 7.26% 0.90% 7.78% (Jun 2025) 6% (Mar 2025) 4.40 L 0.00
Max Healthcare Institute Ltd. Hospital 2295.6 5.62% -0.05% 6.96% (Jun 2025) 5.62% (Oct 2025) 20.00 L 0.00
Cipla Ltd. Pharmaceuticals 1801.6 4.41% -0.18% 5.9% (Dec 2024) 4.41% (Oct 2025) 12.00 L 0.00
Lonza Group AG Foreign equity 1652.2 4.05% -0.01% 5% (Feb 2025) 4.05% (Oct 2025) 2.70 L 0.00
Lupin Ltd. Pharmaceuticals 1649.3 4.04% -0.04% 5.19% (Dec 2024) 4.02% (Aug 2025) 8.40 L 0.00
Ami Organics Ltd. Pharmaceuticals 1554.9 3.81% 0.79% 3.81% (Oct 2025) 2.97% (Jun 2025) 9.00 L 0.00
Fortis Healthcare Ltd. Hospital 1534.6 3.76% 0.06% 3.76% (Oct 2025) 2.86% (Nov 2024) 15.00 L 0.00
Torrent Pharmaceuticals Ltd. Pharmaceuticals 1424 3.49% -0.17% 3.66% (Sep 2025) 2.58% (May 2025) 4.00 L 0.00
Jupiter Life Line Hospitals Ltd. Hospital 1414.2 3.46% 0.26% 3.7% (Jan 2025) 2.84% (Jul 2025) 8.90 L 61.70 k
- indicates change in weight in the portfolio. # indicates a new entry.
No of Debt Holding 1 (Category Avg - 0.87) | Modified Duration 0.00 Years (Category Avg - 0.00)| Yield to Maturity - -- (Category Avg - 0.00%)

Type of Holdings

Security Type
% Weight
Category Average
GOI 0.00% 0.02%
T-Bills 0.07% 0.43%

Investment / Portfolio Grades

Security Type
% Weight
Category Average
Government Backed 0.07% 0.44%
Low Risk 0.00% 0.00%
Moderate Risk 0.00% 0.00%
High Risk 0.00% 0.00%
Very High Risk 0.00% 0.00%
Others 0.00% 0.00%
Name Type of Instrument Weight (%)
TREPS TREPS 4.02%
Net Receivables Net Receivables -0.14%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)

  • Standard Deviation

    Low volatility
    11.96vs13.95
    Category Avg
  • Beta

    Low volatility
    0.84vs0.86
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    1.41vs0.91
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.2vs0.17
    Category Avg
  • Jensen's Alpha

    Poor risk adjusted returns
    3.02vs3.58
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth NA 421.51 4.92 17.03 53.25 43.86 37.50
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth NA 273.51 -0.81 2.65 16.36 27.90 15.61
Quant BFSI Fund - Regular Plan - Growth NA 680.73 4.10 7.82 19.29 25.75 0.00
HDFC Transportation and Logistics Fund - Regular Plan - Growth NA 1733.63 0.81 10.48 23.11 25.46 0.00
Franklin Asian Equity Fund - Growth NA 297.12 4.14 10.18 21.38 25.03 14.27
Nippon India Japan Equity Fund - Growth NA 292.35 2.82 3.35 14.58 22.26 17.18
SBI Banking & Financial Services Fund - Regular Plan - Growth NA 9273.44 3.02 6.26 11.05 21.03 19.27
DSP Banking & Financial Services Fund - Regular Plan - Growth NA 1518.73 2.68 7.30 8.35 20.86 0.00
ITI Banking and Financial Services Fund - Regular Plan - Growth NA 333.18 3.77 7.72 8.27 20.77 13.19
UTI Transportation and Logistics Fund - Growth NA 4008.33 -0.04 9.90 17.95 19.46 23.83

More Funds from SBI Mutual Fund

Out of 139 mutual fund schemes offered by this AMC, 4 is/are ranked 5 * , 7 is/are ranked 4 * , 9 is/are ranked 3 * , 8 is/are ranked 2 * , 10 is/are ranked 1 * , and 101 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
SBI Nifty 50 ETF 4 212190.55 2.73 5.33 6.29 11.18 13.33
SBI Nifty 50 ETF 4 212190.55 2.73 5.33 6.29 11.18 13.33
SBI BSE Sensex ETF 5 123001.46 2.78 5.12 5.16 10.01 12.27
SBI BSE Sensex ETF 5 123001.46 2.78 5.12 5.16 10.01 12.27
SBI Equity Hybrid Fund - Regular Plan - Growth 4 81951.86 1.32 4.60 6.56 15.68 14.21
SBI Liquid Fund - Regular Plan - Growth 3 71091.78 0.48 1.42 2.96 6.56 6.91
SBI Large Cap Fund - Regular Plan - Growth 3 54687.99 2.33 4.52 5.80 9.39 13.86
SBI Contra Fund - Regular Plan - Growth 3 49218.42 3.02 4.74 5.84 6.17 19.94
SBI Focused Fund - Regular Plan - Growth 4 40823.77 3.18 7.53 10.19 14.97 16.67
SBI Arbitrage Opportunities Fund - Regular Plan - Growth 4 39858.59 0.56 1.44 3.01 6.55 7.27
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
Close Outskill Genai